Form 8-K - Current report:
SEC Accession No. 0001104659-20-066080
Filing Date
2020-05-27
Accepted
2020-05-27 07:00:33
Documents
4
Period of Report
2020-05-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2020938d1_8k.htm 8-K 28398
2 EXHIBIT 3.1 tm2020938d1_ex3-1.htm EX-3.1 4935
3 EXHIBIT 99.1 tm2020938d1_ex99-1.htm EX-99.1 11465
4 GRAPHIC image_001.jpg GRAPHIC 29469
  Complete submission text file 0001104659-20-066080.txt   86894
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 20912718
SIC: 2836 Biological Products, (No Diagnostic Substances)